Glaucoma Diagnostic Devices Market: By Product Type Imaging Systems, Retinal Tomography and Angiography Systems, Spectral Domain Optical Coherence Tomography Systems, Tonometers, Visual Field Testing Equipment, Others), By Disease Type, By End Users and Geography
Glaucoma Diagnostic Devices Market size was valued at US$ 360 million in 2023 and is expected to reach US$ 2243 million by 2030, at a CAGR of 28.3% from 2024-2030. Glaucoma is a disease characterized by an increase in the intraocular pressure in the eye that leads to optic nerve damage and causes loss of vision or blindness. The most common types of glaucoma include closed-angle glaucoma and open-angle glaucoma. Glaucoma can be diagnosed by determining the status of the optic nerve, intraocular pressure, and drainage angle. An increase in the geriatric population, escalation in the prevalence rate of glaucoma disease, technological advancements in glaucoma diagnostic devices, and sophisticated healthcare infrastructure in developed countries are expected to fuel the market. However, stringent regulatory guidelines for product approval, high cost of devices, and lack of well-trained professionals in underdeveloped countries may restrain the growth of the market.
Study Period
2024-2030Base Year
2023CAGR
28.3%Largest Market
Asia-PacificFastest Growing Market
North-America
Drivers: High prevalence of glaucoma & rise in geriatric population worldwide. Restraints: Less awareness regarding glaucoma and available surgery devices in underdeveloped economies.
North America glaucoma diagnostic devices market expected to grow at a significant rate due increase in the prevalence of glaucoma (As per, Glaucoma Research Foundation survey, approximately 1 out of 10,000 newborn babies are born with glaucoma disease in U.S.), increase in healthcare expenditure, and rise in awareness about the glaucoma disease. The European market is expected to present lucrative growth due to the adoption of newer diagnostic devices, the rise in prevalence of glaucoma in Italy, Germany, Spain, and Austria, and the presence of a huge number of companies for diagnostic devices in the region. The Asia Pacific is poised to grow at a notable rate due to development in healthcare infrastructure, large patient pool in China, India, and Japan. Latin America is poised to grow at a significant rate due to advances in healthcare infrastructure in emerging countries such as Brazil, expansion of businesses by the market players, and adoption of newer devices. The Middle East and Africa growth attributed to rise in prevalence of glaucoma in Africa region and rise in awareness about the glaucoma diagnosis.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 360 million |
|
Market Size in 2030 |
US$ 2243 million |
|
Market CAGR |
28.3% |
|
By Product Type |
|
|
By Disease Type |
|
|
By End user |
|
Download Free Sample Report
The glaucoma diagnostic devices market size was valued at US$ 360 million in 2023
The glaucoma diagnostic devices market key players are: Carl Zeiss Meditec AG (Germany) Topcon Corporation (Japan) Heidelberg Engineering GmbH (Germany) NIDEK CO., LTD (Japan) Optovue, Incorporated (U.S.) Leica Microsystems (Germany) HAAG-STREIT GROUP (U.S.)
The glaucoma diagnostic devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
